PRISM Stock Indexes
Current Value
% Change (Daily)
% Change (Inception)
Top % Gainers
% Change
Top % Losers
% Change
Semiconductors $110.58 -0.04% 10.58% VLN   4.35% ATOM   -4.73%
Pet Care $131.75 1.92% 31.75% JAGX   9.81% ODC   -5.65%
Aerospace and Defense $115.70 2.22% 15.70% EVEX   16.78% ASTC   -13.48%
AI Datacenter and Infrastructure $229.45 1.34% 129.45% RZLV   8.77% AESI   -6.87%
Wellness $122.67 -0.18% 22.67% SKIN   9.00% HAIN   -51.09%
Biotech $132.05 2.69% 32.05% ACTU   15.13% AQST   -11.93%
Cannabis $98.31 0.67% -1.69% TSNDF   6.50% AAWH   -7.95%
Comms and Media $160.10 1.40% 60.10% APPS   10.71% TSQ   -5.35%
Consumer Products $156.83 3.29% 56.83% REAL   15.82% BOF   -2.65%
Crypto Mining $167.86 1.67% 67.86% WULF   9.36% KULR   -6.53%
Cybersecurity $138.43 1.66% 38.43% RSKD   6.49% ATEN   -6.14%
EV $89.27 4.15% -10.73% GP   27.66% BEEM   -3.48%
Fintech $119.33 3.29% 19.33% BETR   32.51% SHFS   -36.25%
Global Health $144.88 1.24% 44.88% IVA   8.36% LGVN   -13.29%
Healthcare $97.00 3.23% -3.00% CCLD   9.04% LUCD   -4.23%
NextGen Tech & AI $136.06 3.44% 36.06% BNAI   13.57% DRIO   -5.87%
New Energy $117.80 1.70% 17.80% SKYQ   12.39% SAFX   -26.79%
MedTech Index $131.32 1.90% 31.32% HUMA   24.12% TELA   -7.76%
Mental Health $128.17 -1.72% 28.17% NRXP   4.63% BTAIQ   -17.14%
Oil & Gas $127.64 -0.99% 27.64% KGEI   3.60% GLND   -11.54%
Pharmaceuticals $283.04 2.71% 183.04% RXRX   11.23% TKNO   -2.44%
Precious Metals $225.40 3.83% 125.40% NFGC   12.06% UURAF   -5.10%
Psychedelics $489.39 1.68% 389.39% HELP   6.45% MIRA   -4.03%
Space $291.48 2.96% 191.48% CMTL   13.28% RKLB   -6.64%
Sports $115.85 1.86% 15.85% MMA   6.25% GMVHF   -2.26%
Weight Loss $115.54 2.09% 15.54% VKTX   7.46% CRBP   -1.81%
Women’s Health $114.51 2.93% 14.51% VSTM   19.71% PDSB   -7.80%
View All

PRISM View

LanzaTech Backs New LanzaJet Financing as Freedom Pines Moves Toward Commercial Growth

LanzaTech Global, Inc. (NASDAQ: LNZA), a carbon recycling company that converts waste carbon into fuels and chemicals, is backing a new round of financing for its sustainable aviation fuel affiliate LanzaJet. LanzaJet announced on October 1...

Vanda Pauses VQW-765 Program After Phase III Social Anxiety Study Misses Primary Endpoint

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a commercial-stage company with approved treatments in psychiatry, sleep and neurology, provided an update on October 14, 2026 on VQW-765, its investigational drug for anxiety. The company said a P...

Recursion Raises $200 Million as FAP Data and a Sanofi Option Move Its Pipeline Forward

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company that uses an AI-enabled design platform to discover drugs, announced on October 15, 2026 an oversubscribed $200 million stock offering alongside new clin...

Chip Rout Goes Global as Kospi Triggers a Trading Halt, and the PRISM Semiconductors Index Takes a Broad Hit

The sell-off in AI-linked stocks reached chipmakers worldwide on Thursday. South Korea’s Kospi dropped as much as 8% and set off a 20-minute trading halt, and Japan’s Nikkei fell almost 5%. In the US, memory and storage stocks fell agai...

SKYX Completes Deako Merger, Expanding Smart-Home Platform and Builder-Market Reach

Combined company reports an estimated pipeline exceeding 4 million units and expects more than $6 million in annual expense savings SKYX Platforms Corp. (NASDAQ: SKYX) has completed its merger with Deako Inc., combining its ceiling-based...

Hot Inflation Print Sinks Bitcoin Miners and AI Data Center Stocks as Rate-Hike Fears Return

A hotter-than-expected inflation report hit two of PRISM MarketView’s most closely watched groups on Wednesday. Every constituent of the PRISM Crypto Mining Index traded lower, with an average decline of nearly 10%. In the PRISM AI Datace...

Greenland Energy Soars 78% After Trump Says “Massive” Oil Exploration Is Coming to Greenland

Greenland Energy Company (NASDAQ: GLND) shares rose 77.6% to about $3.92 on Wednesday, up from Tuesday’s $2.21 close. That made GLND the top performer in the PRISM Oil & Gas Index. By midday, more than 141 million shares had traded, n...

Electrovaya Expects Record Fiscal 2026 Revenue as Jamestown Plant and ElvaPulse Line Near Launch

Electrovaya Inc. (NASDAQ: ELVA), a lithium-ion battery technology and manufacturing company, provided a business update on October 14, 2026 that points to record revenue for the fiscal year that ended September 30. The company also reported...

Compass Pathways Teams Up With Mental Health Groups to Raise Awareness of Treatment-Resistant Depression

Key Points Compass Pathways announced the first-ever U.S. Treatment-Resistant Depression Awareness Day, with support from NAMI, Mental Health America and the Depression and Bipolar Support Alliance. The campaign aims to improve unde...

Viking Therapeutics Launches Phase 3 SUNRISE Program for Once-Daily Oral VK2735 in Obesity

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced on October 14, 2026 that it has started the SUNRISE Phase 3 clinical program for the oral tablet fo...

MicroVision Takes Its Lidar Airborne as Defense AI Spending Builds

Key Points MicroVision will integrate its MOVIA Air Plus lidar with Robinson Unmanned’s SPIRIT drone for real-time aerial mapping. The deal targets commercial, public safety, security and defense customers, extending MicroVisionâ€...

Hackett Group Maps AI’s Potential to Cut Supply Chain Costs and Speed Deliveries

Key Points The Hackett Group introduced new benchmarks modeling how AI could improve supply chain performance. Potential gains include up to 59% fewer expedited orders, 52% lower forecast error and 41% lower inventory carrying costs...

Bio View

Vivos Signs $12 Million Stock Deal for Stake in SOD Sciences and Joint Ownership of Experimental Test

Key Points Vivos Therapeutics agreed to acquire an 11% fully diluted stake in SOD Sciences and 50% co-ownership of its proprietary early-warning test. Vivos will pay with convertible preferred stock carrying a stated value of $12 mi...

Profound Medical Reports Encouraging TULSA Results and Potential for Wider Access

Key Points A randomized trial found better preservation of erectile function and bladder control with TULSA than with robotic prostate surgery at six months. Additional studies reported favorable patient outcomes, but some patients ...

Pulse Biosciences Expands Thyroid Treatment Access With Clayman Center Partnership

Key Points Pulse Biosciences partnered with the Clayman Thyroid Center in Tampa for commercial use and clinical research involving its nPulse Vybrance System. The center is now treating patients with symptomatic benign thyroid nodul...

Verastem Jumps as VS-7375 Posts 50% Response Rate in Pancreatic Cancer, Backed by $250 Million Raise and CEO Succession Plan

Verastem, Inc. (NASDAQ: VSTM) shares rose about 19% on Wednesday, putting the stock at the top of the PRISM Women’s Health Index. The jump followed the first efficacy data for VS-7375, the company’s oral KRAS G12D inhibitor. In patients...

Rhythm Launches IMCIVREE in Japan, Bringing the First Approved Treatment for Acquired Hypothalamic Obesity

Key Points Rhythm Pharmaceuticals has commercially launched IMCIVREE in Japan for acquired hypothalamic obesity. The launch follows regulatory approval in August and inclusion on Japan’s National Health Insurance drug price list. ...

Arrowhead’s Under-the-Skin Tau Data Puts Brain Delivery in Focus for Alzheimer’s Stocks

Arrowhead cut spinal fluid tau by a mean of 73% without a spinal injection. Denali, Voyager and Annovis are testing other routes to lower tau. Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported interim Phase 1/2a data Wednesday showing that...

Aquestive Hands U.S. Rights to LIBERVANT to Eton as It Prepares for an April 2027 Launch

Aquestive Therapeutics (NASDAQ: AQST) has signed an exclusive U.S. licensing and supply agreement with Eton Pharmaceuticals (NASDAQ: ETON) for LIBERVANT® (diazepam) buccal film. LIBERVANT is Aquestive’s rescue treatment for seizure clust...

Immuron’s Travelan Study Signals Potential for Better Protection Against Travelers’ Diarrhea

Key Points Immuron’s Phase 2 study of once-daily Travelan has been published in Scientific Reports, a journal in the Nature portfolio. The study reported a statistically significant 50% reduction in adverse events related to the E...

BrainsWay Expands Insurance Coverage for Accelerated Deep TMS to Over 70 Million U.S. Lives

Key Points BrainsWay says favorable U.S. insurance policies for its SWIFT Accelerated Deep TMS protocol now cover more than 70 million lives. The expansion creates more potential pathways for patients to access the accelerated depre...

Oncolytics Expands Pelareorep Patent Portfolio, Targeting Protection Into the Late 2040s

Key Points Oncolytics has secured a new patent in several countries covering pelareorep’s use as a cancer immunotherapy, with a corresponding U.S. patent expected soon. Existing patents protect the company’s manufacturing proces...

Hims & Hers Expands in Australia With Women’s Health Platform Launch

Key Points Hims & Hers has launched Hers in Australia, expanding its women’s health services across hair regrowth, menopause, perimenopause and weight management. The launch rebrands Juniper, the women’s health platform that...

vTv Therapeutics Highlights Opportunity to Improve Type 1 Diabetes Care Alongside Automated Insulin Delivery

Key Points A survey presented by vTv Therapeutics found that low blood sugar remains a concern for many adults with type 1 diabetes who use automated insulin delivery systems. After accounting for overlapping responses and weighting...

Q&A Corner

Building Regulated Infrastructure Across Traditional and Digital Asset Markets

This interview contains forward-looking statements, including statements regarding the proposed acquisitions, expected closing timelines, anticipated financial contributions and accretion, and planned regulatory filings. These statements ar...

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup